上海传秋生物科技有限公司 www.chuanqiubio.com

人白细胞介素 18 定量分析酶联免疫检测试剂盒

本试剂盒仅供科研使用。用于体外定量检测人血清、血浆或细胞培养上清液中的 IL-18 浓度。使用前请仔细阅读说明书并检查试剂组

分是否完整。如有产品包装破损或质量投拆，请在收到货一个月之内联系我们。

IL-18简介：

白介 18（IL-18）是一个 18 kDa 的细胞因子，结构上与 IL-1 极其相似，对 T 细胞的活化有重要影响。IL-18 的前体缺少信号肽，前体

由 IL-1beta 转换酶（ICE）裂解为成熟的 IL-18。

有报道称 IL-18 由下列细胞产生：树突状细胞、活化的巨噬细胞、凯夫勒细胞、角化细胞、肠内皮细胞、格根包尔氏细胞、肾上腺皮

质细胞等。其中有报道称人的角化细胞是 IL-18 的主要产生源。

IL-18 对 T 辅助细胞起作用，其效果是与 IL-12 协同强烈刺激 T 辅助细胞产生 IFN-γ 。当然，IL-18 也有许多其它的效用，包括刺激

外周血中由单核细胞产生 IFN-γ 和 GM-CSF 水平的升高，刺激 T 细胞产生 Th1 类的细胞因子如 IL-2、IFN-γ 和 GM-CSF 等，提高 Th1 类

的细胞表面的 Fas 配体的表达。此外，在治疗肿瘤、感染和自身免疫方面，IL-18 也是一个重要的预后指标。

检测原理:

本试剂盒采用双抗体夹心ELISA法检测样本中IL-18的浓度。IL-18捕获抗体已预包被于酶标板上，当同时加入标本或参考品和检测抗

体时，其中IL-18蛋白上的不同位点会与捕获抗体和检测抗体结合，形成夹心复合物，锚定在固相载体板上，其它游离的成分通过洗涤的过

程被除去。随后加入辣根过氧化物酶标记的亲合素。生物素与亲合素特异性结合，亲合素连接的酶就会与夹心的免疫复合物连接起来；其

它游离的成分通过洗涤的过程被除去。最后加入显色剂，若样本中存在IL-18将会形成免疫复合物，辣根过氧化物酶会催化无色的显色剂氧

化成蓝色物质，在加入终止液后呈黄色。通过酶标仪检测，读其450nm处的OD值，IL-18浓度与OD450值之间呈正比，通过参考品绘制标准曲

线，对照未知样本中OD值，即可算出标本中IL-18浓度。

人IL-18定量分析酶联免疫检测试剂盒组成:

组分 规格（96T/48T）

人IL-18预包被板 12条/6条

样本分析缓冲液 5ml/3ml

人IL-18标准品稀释液 10ml/5ml

人IL-18标准品 4支/2支(冻干)

生物素化抗体 5ml/2.5ml

HRP酶稀释液 11ml/5.5ml

5000×HRP连接的酶结合物 2.2μ L/1.1μ L

浓缩洗涤液 30ml/15ml

TMB底物 10ml/5 ml

终止液 5ml/3 ml

封板胶纸 3/2张

说明书 1份

标本收集:

1.标本的收集请按下列流程进行操作；

A.细胞上清标本离心去除悬浮物后即可；

B.血清标本应是自然凝固后，取上清，避免在冰箱中凝固血液；

C.血浆标本，推荐用EDTA的方法收集若待测样本不能及时检测，D.标本收集后请分装，冻存于－20℃，避免反复冻融。

2.血清标本不应添加任何防腐剂或抗凝剂；

3.标本应清澈透明，检测前样本中如有悬浮物应通过离心去除。

4.请勿使用溶血，高血脂或污染的标本检测，否则结果将不准确。

注：人血清或血浆样本请用样本分析缓冲液做倍比稀释后再检测。

注意事项:

1.试剂盒请保存在2～8℃。

2.浓缩洗涤液因在低温下可能有结晶，请水浴加热使结晶完全溶解后再配制工作液。

3.标准品复溶加样后，剩余部分请丢弃。

4.底物请勿接触氧化剂和金属。

5.加样时，请及时更换枪头，避免交叉污染。

6.严禁混用不同批号的试剂盒组份。

7.充分混匀对保证反应结果的准性很重要，在加液后请轻轻叩击边缘以保证混匀。

8.室温反应，请严格控制在25～28℃。

9.洗涤过程是至关重要的，洗涤不充分会使精确度下降并导致结果误差较大。

10.试验中标准品和样本检测时建议作双复孔。

11.加样过程中避免气泡的产生。

12.血清和血浆标本的检测时，检测抗体的孵育时间应适当延长。

检测前准备工作:

1.试剂盒自冰箱中取出后应置室温（25～28℃）平衡20分钟；每次检测后剩余试剂请及时于2～8℃保存。

2.将浓缩洗涤液用双蒸水或去离子水稀释(1份加19份水)。

3.如有5X准品稀释液，请按所需量用双蒸水或去离子水稀释(1份加4水)。

4.标准品: 按标签复溶体积加入标准品稀释液复溶使IL-18终浓度达到5000pg/ml，室温反应，请严格控制在25～28℃，静置15~20分钟后轻

轻混悬（建议抽吸几次）待彻底溶解，用标准品稀释液倍比梯度稀释后依次加入检测孔中。（标准曲线取七个点，最高浓度为5000 pg/ml,

标准品稀释液直接加入作为0浓度.）

洗涤方法:

自动洗板机或人工洗板：每孔洗涤液为300ul，注入与吸出间隔15-30秒。洗板5次。最后一次洗板完成后将板倒扣着在厚吸水纸上用力拍干。

实验过程需自备的材料：

1.不同规格的加样枪及相应的枪头；

2.酶标仪；

3.自动洗板机；

4.去离子水或双蒸水；

操作步骤:

1.通过计算并确定一次性实验所需的板条数，取出所需板条放置在框架内，暂时用不到板条请放回铝箔袋密封，保存于4℃。

上海传秋生物科技有限公司 www.chuanqiubio.com人IL-18标准曲线

0

0.5

1

1.5

2

2.5

0 156.25 312.5 625 1250 2500 5000

人IL-18浓度（pg/ml）

O

D值

上海传秋生物科技有限公司 www.chuanqiubio.com

2.建议设置本底较正孔，即空白孔,设置方法为该孔只加TMB显色液和中止液。每次实验均需做标准品对照并画出标准曲线。

3.分别将标本或不同浓度标准品(100ul/孔)加入相应孔中，对于血清或血浆标本，请加入50 ul样本分析缓冲液后加50 ul标本, 如稀释量

大，请将样本与样本分析缓冲液等量加入，不足部分用标准品稀释液补充至100ul。

4.加入生物素化抗体工作液(50ul/孔)。用封板胶纸封住反应孔，室温（25～28℃）孵育120分钟。

5.洗板5次，且最后一次置厚吸水纸上拍干。

6.加入亲和素连接的HRP酶工作液(100ul/孔)。用封板胶纸封住反应孔，避光室温（25～28℃）孵育30分钟。

7.洗板5次，且最后一次置厚吸水纸上拍干。

8.加入显色剂TMB100ul/孔，避光室温（25～28℃）孵育20分钟。

9.加入终止液50ul/孔,混匀后即刻测量OD450值。

结果判断:

1.复孔的值在20%的差异范围内结果才有效，复孔的值平均后可作为测量值。

2.每个标准品或标本的OD值应减去本底校正孔的OD值。

3.手工绘制标准曲线。以标准品浓度作横坐标，OD值作纵坐标，以平滑线连接各标准品的坐标点。通过标本的OD值可在标准曲线上查出其

浓度。

4.若标本 OD 值高于标准曲线上限，应适当稀释后重测，计算浓度时应乘以稀释倍数。

典型数值和参考曲线

浓度pg/ml 典型OD值1 典型OD值2 OD平均值

0 0.1491 0.1151 0.1321

156.25 0.3517 0.2965 0.3241

312.5 0.4672 0.4502 0.4587

625 0.6943 0.6755 0.6849

1250 0.9816 0.9724 0.977

2500 1.4186 1.3492 1.3839

5000 2.0412 1.9262 1.9837

人IL-18参考标准曲线

注意：本图仅供参考，应以同次试验标准品所绘标准曲线计算标本含量。

灵敏度，特异性和重复性:

1.灵敏度：多次重复结果表明，最小检出量为35.8pg/ml。上海传秋生物科技有限公司 www.chuanqiubio.com

2.特异性：与人 IL- - - -18 sR，小鼠 IL-18，大鼠 IL-18 等没有交叉反应。

3.重复性：板内，板间变异系数均<10%.

参考文献:

1) Alsaleh, G., et al., J. Immunol. 182, 5088-5097 (2009)

2) Tada, H., et al., Infect. Immunol. 73, 7967-7976 (2005)

3) Rouabhia, M., et al., Infect. Immunol. 75, 3739-3746 (2002)

4) Vujisic, S., et al., Hum. Reprod. 21, 2650-2655 (2006)

5) Narita, M., et al., Clin. Diagn. Lab. 7, 909-914 (2000)

6) P arikh, C. R., et al., J. Am. Soc. Nephrol. 16, 3046-3052 (2005)

7) Baratin, M. L., et al., PNAS. 102, 14747-14752 (2005)

8) Kaizu, M., et al., Virology 313, 8-12 (2003)上海传秋生物科技有限公司 www.chuanqiubio.com

ELISA Kit for the Quantitative Analysis of Human IL-18

The human IL-18 ELISA (enzyme-linked immunosorbent assay) kit is used for detection of human IL-18 in cell culture

supernatants,human serum and plasma.THE ELISA KIT IS FOR RESEARCH USE ONLY. Please read this instruction manual carefully

and check out the material provided before use, and you can contact with our company if any questions. You can enter our website or call

us for other aim.

Introduction

Interleukin 18 (IL-18) is an 18 kDa cytokine, structurally similar to IL-1, with great effects on T-cell activation. The precursor of IL- 18

is lacking a signal peptide and the mature molecule is formed by IL-1 beta-converting enzyme (ICE, caspase-1) cleaved the precursor.

It has been reported that IL-18 is produced from dendritic cells, activated macrophages, Kupffer cells, keratinocytes, intestinal

epithelial cells, osteoblasts and adrenal cortex cells. Human keratinocytes have been found to be the major producers of IL-18.

IL-18 acts on T helper 1-type (Th1) cells, and in combination with IL-12 strongly induces production of IFN-γ by these cells.

Pleiotropic effects of IL-18 have also been reported, including enhancement production of IFN-γ and GM-CSF in peripheral blood

mononuclear cells, production of Th1 cytokines, IL-2, GM-CSF and IFN-γ in T cells, enhancement of Fas ligand expression by Th1 cells.

Further more,an important role of IL-18 has been shown in clinical implications, in the role of IL-18 modulation in tumours, infections, and

autoimmune and inflammatory diseases.

Principles of the Test

The kits is a solid sandwich enzyme-linked immunosorbent assay for detection of human IL-18. An anti-human IL-18 monoclonal

antibody has been absorbed onto the wells of the microtiter strips provided. Samples including specimens or standards and human IL-18

biotin-conjugated antibody were pipetted into wells. The different epitope of human IL-18 would be captured by the coated antibody and

the biotin-conjugated antibody, which formed a sandwich. Free protein or antibody would be removed during a wash step.

Streptavidin-HRP would be added and binds to the biotin conjugated antibody, then free Streptavidin-HRP would be removed during a

wash step. After this, subtrate solution would be added and catalyzed by the HRP, and a coloured product is formed. The intensity of the

colored product is used to calculate in proportion to the amount of human IL-18 in the original specimen.

Materials provided with the kits:

reagent 96/48Test Kit

Assay Buffer 5ml/3 ml

IL-18 Antibody-Coated Wells 12 strips/6 strips

Standard Diluent 10 ml/5ml

IL-18 Standard 4/2vial(s)

Detetion Antibody 5ml/2.5ml

5000╳Streptavidin-HRP 2.2μ L /1.1μ L

HRP Dilute 11ml/5.5ml

Wash Buffer Concentrate 20× 30ml/15ml

TMB 10ml/5 ml

Stop Solution 5ml/3 ml

Plate Covers 3/2

Complete Instruction Manual 1Specimen Collection

1.Collecting specimen as following:

A.The particulate of the cell culture supernatants should be removed before use.

B.Serum was obtained from clot at room temperature.

C.Please collect plasma with EDTA.

D.Assay immediately or store samples at －20℃. Avoid free-thaw cycles.

2．Antiseptic and anticoagulant should not appear in Serum samples.

3.Any particulate should be removed from samples before use.

4. Do not use grossly hemolyzed or lipemic samples.

Note: Strongly recommend that the serum and plasma samples should be diluent as doubling dilution before use.

Precautions for use:

1.Please storage the Kit at 2～8℃。

2. Washing buffer concentrate may have crystal in low temperature, and you can melt its in water-bath before use.

3. Please discard the dissolved standard after 3 days for use.

4、Avoid contact of substrate solution with oxidizing agents and metal.

5、Usage of disposable pipette tips avoid microbial contamination or cross-contamination of reagents or specimens.

6. Do not mix or substitute reagents with those from other lots or other sources.

7. To ensure the adequate mixure of added reagents, please tap gently the plate after the wells were filled with liquid.

8. Incubation temperature should be 25～28℃.

9. Wash step was crucial for whole assay process.

10. Duplicate wells of the same sample were recommended in assay process.

11. Avoid the foam while pour the liquid into wells.

12、For serum or plasma samples ,the biotin-conjugated antibody should be incubate for at least 90 minutes.

Reagent Preparation

1.The reagents should be warmed up to room temperature before use. The remanent reagents must reseal and put into refrigeratory

again as soon as possible.

2.Dilute 1ml of wash buffer Concentrate into 19ml deionized or distilled water to work.

3. If you have a 5x standard diluent, please dilute it with double steaming water or deionized water.

4. Add standard diluent to the bottle according to the volume of the label and wait 15 minutes for complete dissolution. And in turn add the

half concentration diluent by standard diluent .

Wash step:

Automated microplate washer or operating by pipette: Each well should be pour into300ul wash buffer and soak 15 or 30 seconds,then

be aspirated, five times process were repeated. After the last wash, remove remaining wash buffer by aspirating.Invert the plate and blot

it against clean paper towels.

Materials Required But Not Provided

1. pipettes and pipette tips

2. Microwell strip reader capable of reading at 450 nm (540 nm as optional reference wave length)

3. automated microplate washer

4.Glass-distilled or deionized water

Assay procedure

1.The needed strips were putted into the frame, the remains were returned into foil pouch and resealed.

2.Blank well were recommended, which only color reagent and stop solution be added. It is suggested that each testing with gradient

density of standard for standard curve.

3.Add 100ul of standard or sample. If assay the serum sample,you should add 50μ l assay buffer with 50μ l sample into the wells,if the

protein concentration is higher than the range of the Kit, add the same quantitys assay buffer with the sample, the deficiency should be

complemented with sample diluent to 100μ l per well..

4.Add 50ul of detetion antibody. Cover with the Plate Covers provided.Incubate for 2 hours at room temperature.

5.Five times wash process were repeated.

6.Add 100ul of Streptavidin-HRP. Cover with the Plate Covers provided. Lucifugal incubation for 30 minutes at room temperature.

7.Five times wash process were repeated.

8.Add 100ul of TMB，Lucifugal incubation for 20 minutes at room temperature.

9.Add 50ul of stop solution to each well, determine the optical density of each well within 10 minutes.

Calculation of Results

1.Duplicates should be within 20 per cent of the mean. Average absorbance values for each set of duplicate samples were used as

detection results.

2.The blank absorbance values of subtract should be deducted.

3.Drawing a best fit curve through the points of graph. Draw the standard curve by plotting assayed OD valure (on the Y axis) vs.

concentration (on the X axis). The sample concentration was obtained based on its OD value founding in the standard concentration

curve.

4.If the values obtained are not within the expected range of the standard, Samples should be dilute and assay again.

Typical Data and Standard Curve

concentration

(pg/ml)

Typical data 1 Typical data 2 Average

0 0.1491 0.1151 0.1321

156.25 0.3517 0.2965 0.3241

312.5 0.4672 0.4502 0.4587

625 0.6943 0.6755 0.6849

1250 0.9816 0.9724 0.977

2500 1.4186 1.3492 1.3839

5000 2.0412 1.9262 1.9837

Human IL-18 standard curve上海传秋生物科技有限公司 www.chuanqiubio.com

Sensitivity, Specificity, Repeatability

Sensitivity: repeated assays were evaluated and the minimum detectable dose was 35.8pg/ml.

Specificity : No significant cross-reactivity or interference with humanIL- - - -18 sR and

mouse IL-18,rat IL-18

Repeatability: The coefficient of variation between wells or plates is less than 10 percent.

REFERENCES

1) Alsaleh, G., et al., J. Immunol. 182, 5088-5097 (2009)

2) Tada, H., et al., Infect. Immunol. 73, 7967-7976 (2005)

3) Rouabhia, M., et al., Infect. Immunol. 75, 3739-3746 (2002)

4) Vujisic, S., et al., Hum. Reprod. 21, 2650-2655 (2006)

5) Narita, M., et al., Clin. Diagn. Lab. 7, 909-914 (2000)

6) P arikh, C. R., et al., J. Am. Soc. Nephrol. 16, 3046-3052 (2005)

7) Baratin, M. L., et al., PNAS. 102, 14747-14752 (2005)

8) Kaizu, M., et al., Virology 313, 8-12 (2003)